The Carlyle Group Inc. 13D and 13G filings for Vera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-02 5:01 pm Sale |
2023-07-18 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
1,872,764 4.200% |
-544,073 (-22.51%) |
Filing |
| 2023-07-05 4:17 pm Sale |
2023-06-28 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
2,416,837 5.500% |
-543,394 (-18.36%) |
Filing |
| 2023-04-13 4:06 pm Sale |
2023-03-28 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
2,960,231 6.700% |
-9,925 (-0.33%) |
Filing |
| 2022-08-11 5:01 pm Purchase |
2022-08-01 | 13D | Vera Therapeutics, Inc. VERA |
Carlyle Group Inc. CG |
2,970,156 11.100% |
2,970,156 (New Position) |
Filing |